Summary
The aetiology of weight loss in patients with Parkinson's disease is likely to be multifactorial. We studied 15 patients with Parkinson's disease and 15 age-and sex-matched controls and looked for evidence of malabsorption due to small bowel bacterial overgrowth or alteration of intestinal permeability. There was a marked increase in orocaecal transit time in the patients with Parkinson's disease, although lactulose hydrogen breath testing did not show evidence of small bowel bacterial contamination. Intestinal permeability measured by the differential sugar absorption test was also deranged. There was reduced absorption of mannitol in patients with Parkinson's disease while lactulose absorption was similar in both groups, suggesting decreased non-mediated uptake across the enterocyte brush border membrane in patients with Parkinson's disease. Keywords 
PROCEDURE
Lactulose hydrogen breath test Laxatives were discontinued for 48 hours prior to the procedure. All subjects were studied after an overnight fast having been asked to avoid foods likely to generate hydrogen for the 24 hours prior to the test. None had received antibiotics for at least two months and patients were asked to refrain from smoking on the morning of the test. Lactulose (10 g) was ingested with 50 ml ofwater and end expiratory samples of breath analysed for hydrogen content before and at 5-minute intervals for 30 minutes and every 15 minutes for a further 150 minutes after. End expiratory breath was analysed using an EC60 electrochemical hydrogen sensor (Bedfont Sittingbourne, Kent). The test duration was 180 minutes. Orocaecal transit time was defined as the time between ingestion of the lactulose and the first definite and sustained rise in breath hydrogen.89 In practice, a rise of at least 5 ppm above fasting levels in the end expiratory hydrogen concentration was taken as the transit time. An early rise in breath hydrogen followed by a fall and later rise signifies bacterial overgrowth in the small intestine. [7] [8] [9] Differential sugar absorption test A lactulose/mannitol differential sugar absorption test was performed. The amount of man-nitol recovered in urine in normal subjects is 40-100 times greater than the amount of lactulose recovered, as normal subjects absorb less than 1% of the lactulose administered. If intestinal permeability is abnormal there is an alteration in the amount of the sugars absorbed. Expressing the percentage urinary recovery of lactulose as a ratio of that of mannitol eliminates the effects of variability in absorption due to delayed gastric emptying or transit time through the intestine. Such effects would invalidate permeability tests using a single probe molecule. In addition, the differential sugar absoption test remains valid in the presence of renal impairment and does not depend on the accuracy of urine collection.
A sample of urine was collected after an overnight fast. Subjects swallowed a mixture of 5 g of lactulose, 2 g of mannitol and 22.3 g of glucose (as an osmotic filler) in 100 ml of water. Urine was collected for the next five hours into a container to which 1 ml of 20% (w/v) chlorhexidine was added as preservative. The volume was recorded prior to storing a small sample (10 ml) at -20°C until analysis. Subjects fasted throughout the test but were allowed to drink up to 250 ml of water two hours after ingestion of the sugars.
Analytical methods Mannitol in urine was estimated as its trimethylsilyl derivative by gas liquid chromatography using alpha-methylglucose as internal standard."5 A Pye-Unicam gas chromatograph fitted with flame ionisation detectors and linked to a Pye-Unicam PU 4810 computing integrator was used. The column (2 m, 3 mm internal diameter) used was 10% OU17 or gas-chrom Q and column conditions were as follows: oven temperature 190°C, injector temperature 210°C, detector temperature 350°C, carrier gas (nitrogen) flow rate 40 ml/ min. Lactulose in urine was determined by enzymic hydrolysis to fructose and galactose by beta-galactosidase followed by detection of fructose by a NADP+-linked spectrophotometric assay. '6 Statistical methods Data are described as median (range) percentage recoveries of each probe sugar in a five hour urine collection. Statistical analysis was performed with Mann-Whitney U test, Chisquare and Spearman's rank correlation (rJ) where appropriate. A p-value of 0.05 was considered significant.
Results
The patients had a mean disease duration of six '31 In elderly subjects the excretion of both sugars is reduced but the ratio of the sugars is not significantly different to young subjects and the test remains reliable in older subjects.32 The reduced absorption of monosaccharides is postulated to be due to a loss of absorptive surface area which is usually due to villous atrophy. The increased absorption ofdisaccharides is thought to be due to epithelial injury, increased shedding of cells at extrusion zones, or changes in the tight junction permeability. 1, 29, 31 We found that the Parkinson's disease patient group showed decreased urinary recovery of mannitol with normal recovery of lactulose. This excludes gross changes in absorptive surface area (eg, villous atrophy) since the urinary recovery of both sugars would be similarly decreased with a normal lactulose:mannitol ratio. Similarly, changes in orocaecal transit time would be expected to affect the absorption of both sugars equally leaving the lactulose:mannitol ratio unaltered. The only explanation for the decreased mannitol recovery observed in this study is a specific alteration in the enterocyte brush border membrane. Several types of enteric disease,33 together with enteropathogenic Escherichia coli,3 cause atrophy of the brush border microvilli. Similar alterations in Parkinson's disease patients would be expected to decrease mannitol absorption whilst leaving that of lactulose unchanged, and may be one of the factors involved in under nutrition in Parkinson's disease. Alternatively, changes in the fluidity of the brush border membrane could produce similar results. Further investigation is required to confirm and explain these findings. This will require upper gastrointestinal endoscopy and examination of small intestinal biopsies by both light and electron microscopy.
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Learning points * patients with Parkinson's disease often lose weight * the aetiology has not been fully elucidated * dietary deficiency and malabsorption should be excluded * an increase in energy expenditure is a contributory factor
